Vincenzo Sammartano

Statistics

Publications

Citations

118

H-Index

Active since

2019

Affiliations

Azienda Ospedaliera Universitaria Senese(Current)

University of Pisa

University of Siena

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Ospedale di Parma

Vincenzo Sammartano is an author at Azienda Ospedaliera Universitaria Senese specializing in molecular medicine, immune response to vaccination, and mrna vaccine technology.

ORCID

Publications per year

2019–2023

Publications

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose

Fabio Fiorino, Anna Sicuranza, Annalisa Ciabattini et al. · Biomedicines · 2021 · 28 citations · Full text

Veterinary Medicine, Immunology, Molecular Medicine +15

Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy

Monica Bocchia, Anna Candoni, Erika Borlenghi et al. · Hematological Oncology · 2019 · 27 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients

Fabio Fiorino, Annalisa Ciabattini, Anna Sicuranza et al. · Frontiers in Immunology · 2022 · 20 citations · Full text

Life Sciences, Immunology, Molecular Medicine +17

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells

Paola Pacelli, Adele Santoni, Anna Sicuranza et al. · Frontiers in Pharmacology · 2023 · 18 citations · Full text

Medicine, Hematology, Oncology +17

Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients

Alessandro Gozzetti, Francesca Bacchiarri, Vincenzo Sammartano et al. · Frontiers in Oncology · 2020 · 15 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 6